News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dana-Farber researchers report that multiple myeloma is driven to spread by a subset of the myeloma cells within a patient’s body, and that attacking those specific subsets with targeted drugs may be better targets for therapy.

Tags: BasicResearch, MultipleMyeloma

  • Dana-Farber and colleagues report that an oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) in a phase 2 clinical trial.

Tags: Leukemia

  • The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study by researchers at Dana-Farber Cancer.

Tags: BasicResearch, MultipleMyeloma

  • Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.

Tags: Lymphoma, Immunotherapy

  • The Leapfrog Group has named Dana-Farber Cancer Institute to its annual list of Top Hospitals for the first time.

Tags: Honors, PatientSafety

  • Fifty-seven physicians and surgeons affiliated with Dana-Farber have been named to Boston magazine's annual "Top Doctors" guide.

Tags: Honors

  • Scientists analyzed tissue samples from patients who had — and had not — responded to a promising new immunotherapy drug. The study could help identify patients most likely to respond to the new drug, which blocks PD-L1.

Tags: Melanoma, Immunotherapy

  • Three Dana-Farber Cancer Institute faculty are named Fellows of the American Association for the Advancement of Science (AAAS).

Tags: Appointments, Honors

  • Scientists will be better able to trace how genetic changes give rise to diseases ranging from cancer to Huntington’s disease with a new map of protein-protein interactions within human cells produced by researchers at the Center for Cancer Systems Biology (CCSB) at Dana-Farber and associates around the world.

Tags: Genomics, Genetics

  • A research team led by Dana-Farber Cancer Institute and Brigham and Women’s Hospital has uncovered surprising new findings that underscore the role of an important signaling pathway, already known to be critical in cancer, in the development of type 2 diabetes.

Tags: BasicResearch

Showing 21-30 of 570 items